Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Residual Abdominal Lymphadenopathy after Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Regardless of MRD Status in Advanced Chronic Lymphocytic Leukemia (CLL)

Moritz Fürstenau, MD, Jasmin Bahlo, PhD, Anna-Maria Fink, MD, Elisabeth Lange, Peter Dreger, MD, Martin Dreyling, MD PhD, Georg Hess, Matthias Ritgen, MD, Michael Kneba, Hartmut Döhner, MD, Stephan Stilgenbauer, MD PhD, Clemens-Martin Wendtner, Valentin Goede, MD, Kirsten Fischer, MD, Sebastian Böttcher, Michael Hallek, Barbara Eichhorst

Blood (2018) 132 (Supplement 1): 4430.

https://doi.org/10.1182/blood-2018-99-113280

Published: 2018

Journal Articles

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Varsha Gupta, MD, Shreya Gor, MD, Anmol S Cheema, MD, Ravneet Bajwa, MD, Carrie Edelman, MD, Ethan Jeffrey Wasserman, MD

Blood (2018) 132 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2018-99-118826

Published: 2018

Journal Articles

Marked Re-Expansion of Chimeric Antigen Receptor (CAR) T Cells and Tumor Regression Following Nivolumab Treatment in a Patient Treated with Axicabtagene Ciloleucel (axi-cel; KTE-C19) for Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Brian T. Hill, MD PhD, Zachary J. Roberts, MD PhD, John M. Rossi, MS, Mitchell R. Smith, MD PhD

Blood (2017) 130 (Supplement 1): 2825.

https://doi.org/10.1182/blood.V130.Suppl_1.2825.2825

Published: 2017

Journal Articles

Splenic Diffuse Red Pulp Small B Cell Lymphoma: Transformation To Diffuse Large Cells B Lymphoma

Evandro Dantas Bezerra, Leila Patricia Fontenele, MD, Juliana Pereira, PhD, Luis Alberto de Padua Covas Lage, Felipe Maciel, Leticia Barquinero, Priscila R Carvalho, Scheila Siqueira, Elvira RP Velloso, MD, PhD

Blood (2013) 122 (21): 5070.

https://doi.org/10.1182/blood.V122.21.5070.5070

Published: 2013

Journal Articles

A Pathologic Abdominal Ultrasonography At Diagnosis Of CLL Significantly Reduces The Time To Progression In Patients With Rai 0 Or Rai 1 Disease

Fausto Rossini, MD, Caterina Cecchetti, Francesca Farina, Marianna Sassone, Chiara Scollo, Sara Pezzatti, Silvia Bolis, Angelo Belotti, Sofia Bozzani, Alessandra Perego, Enrico Maria Pogliani, MD

Blood (2013) 122 (21): 2869.

https://doi.org/10.1182/blood.V122.21.2869.2869

Published: 2013

Journal Articles

Fast Achievement Of a First Metabolic Complete Remission In a Lung Transtplanted Patient With Multiple Comorbidities and a CD30 Positive Anaplastic Large Cell Post-Transplant Lymphoproliferative Disorder (T-PTLD/ALCL) By Treatment With Brentuximab Vedotin Monotherapy

Ella Willenbacher, MD, Alfons Kreczy, MD, Christian Uprimny, MD, Brigitte Bucher, MD, Guenther A. Gastl, MD, Wolfgang Willenbacher, MD

Blood (2013) 122 (21): 5124.

https://doi.org/10.1182/blood.V122.21.5124.5124

Published: 2013

Journal Articles

The KIT D816V Allele Burden in Systemic Mastocytosis Is Strongly Associated with Disease Subtype.

Juliana Schwaab, MD, Philipp Erben, MD, Hans-Peter Horny, MD, Martina Teichmann, MD, Georgia Metzgeroth, MD, Thomas Ernst, MD, Karl Sotlar, MD, Martin C Mueller, MD, Alexander Marx, MD, Karin Hartmann, MD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, Wolf Karsten Hofmann, MD, PhD, Andreas Reiter, MD

Blood (2012) 120 (21): 2859.

https://doi.org/10.1182/blood.V120.21.2859.2859

Published: 2012

Journal Articles

Pancytopenia a Presentation of disseminated Histoplasmosis

Sakeer Hussain, MD

Blood (2012) 120 (21): 4687.

https://doi.org/10.1182/blood.V120.21.4687.4687

Published: 2012

Journal Articles

Crizotinib in ALK-Positive Diffuse Large B-Cell Lymphoma: A Case Report

Maxi Wass, MD, Timo Behlendorf, MD, Ulrike Gläser, MD, Jörn Rüssel, MD, Fredericke Güntsch, MD, Jordan Karin, MD, Hans-Joachim Schmoll, MD, PhD

Blood (2012) 120 (21): 4862.

https://doi.org/10.1182/blood.V120.21.4862.4862

Published: 2012

Journal Articles

Treatment of Burkitt's Like Lymphoma: A Single Institution Case Series

Vishal Ranpura, MD, Shilpan S. Shah, MD

Blood (2011) 118 (21): 4962.

https://doi.org/10.1182/blood.V118.21.4962.4962

Published: 2011

Journal Articles

Critical Evaluation of Diverse Clinical, Laboratory, Radiological and Histological Parameters Indicating Gastrointestinal Involvement for Diagnosis of Indolent and Aggressive Systemic Mastocytosis

Georgia Metzgeroth, MD, Juliana Schwaab, MD, Martina Teichmann, MD, Alexander Marx, MD, Henrik J. Michaely, MD, Hans Peter Horny, MD, Nicholas C.P. Cross, PhD, Andreas Hochhaus, MD, Wolf Karsten Hofmann, MD, PhD, Andreas Reiter, MD

Blood (2011) 118 (21): 5159.

https://doi.org/10.1182/blood.V118.21.5159.5159

Published: 2011

Journal Articles

A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab In Relapsed CLL/SLL.

Jennifer R Brown, MD, PhD, Bradley Messmer, Lillian Werner, Evgeny Mikler, David C. Fisher, MD, Ann LaCasce, MD, MSc, Philippe Armand, MD, PhD, Eric D Jacobsen, MD, Virginia Dalton, Bethany Tesar, Stacey M Fernandes, Sean McDonough, MS, Jerome Ritz, MD, Laura Z Rassenti, PhD, Thomas J. Kipps, MD, PhD, Donna Neuberg, ScD, Arnold S. Freedman, MD

Blood (2010) 116 (21): 1381.

https://doi.org/10.1182/blood.V116.21.1381.1381

Published: 2010

Journal Articles

“Complete” Remission in Chronic Lymphocytic Leukemia (CLL) Is Strongly Affected by the Use of CT Scanning: Results from a Prospective Randomized Trial of Fludarabine Plus Cyclophosphamide (Flu/Cy) with or without Genasense (Oblimersen) in Patients with Relapsed or Refractory Disease.

Peter Maslak, MD, James Caravelli, MD, Asher Alban Chanan-Khan, MD

Blood (2006) 108 (11): 2834.

https://doi.org/10.1182/blood.V108.11.2834.2834

Published: 2006

Journal Articles

Computed Tomography (CT) Predicts Response Duration in Patients with Chronic Lymphocytic Leukemia (CLL) in Complete Response (CR) by Conventional, NCI-Working Group, Criteria.

Francesc Bosch, MD, Ana Muntañola, MD, Ana Ferrer, MD, Marcos González, MD, Eva Gine, MD, Eugenia Abella, MD, Santi Gardella, MD, Javier Briones, MD, Eva González-Barca, MD, Lourdes Escoda, MD, Elena Pérez-Ceballos, MD, Antoni Asensi, MD, Maria José Sayas, MD, Joan Besalduch, MD, Emili Montserrat, MD

Blood (2006) 108 (11): 2835.

https://doi.org/10.1182/blood.V108.11.2835.2835

Published: 2006

Journal Articles

Prognostic Factors in Hodgkin’s Disease - Analysis of 211 Patients from a Single Institution.

Janet G. Grudeva, PhD, Ivanka Nenova, PhD, Nonka Mateva, PhD, Nikola Ananoshtev, Phd

Blood (2006) 108 (11): 4678.

https://doi.org/10.1182/blood.V108.11.4678.4678

Published: 2006

Journal Articles

Mitochondria Damage Leading to High Frequency of Lymphoma and Myeloproliferative Disorder in Transgenic Mice Overexpressing a Human 8-Oxoguanine DNA-Glycosylase Gene.

Qin Huang, MD, PhD, Haihong Zhang, M.D., Ph.D, Lawrence M. Weiss, M.D., Chun-Yang Fan, M.D., Ph.D

Blood (2006) 108 (11): 2246.

https://doi.org/10.1182/blood.V108.11.2246.2246

Published: 2006

Journal Articles

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

Andres O. Soriano, MD, Michael Thompson, MD, Jorge Romaguera, MD, Alma Rodriguez, MD, Fredrick B. Hagemeister, MD, Luis Fayad, MD, Joan H. Admirand, MD, Barbara Pro, MD

Blood (2005) 106 (11): 3892.

https://doi.org/10.1182/blood.V106.11.3892.3892

Published: 2005

NARROW

Residual Abdominal Lymphadenopathy after Intensive Frontline Chemoimmunotherapy Is Associated with Inferior Outcome Regardless of MRD Status in Advanced Chronic Lymphocytic Leukemia (CLL)

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Marked Re-Expansion of Chimeric Antigen Receptor (CAR) T Cells and Tumor Regression Following Nivolumab Treatment in a Patient Treated with Axicabtagene Ciloleucel (axi-cel; KTE-C19) for Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Splenic Diffuse Red Pulp Small B Cell Lymphoma: Transformation To Diffuse Large Cells B Lymphoma

A Pathologic Abdominal Ultrasonography At Diagnosis Of CLL Significantly Reduces The Time To Progression In Patients With Rai 0 Or Rai 1 Disease

Fast Achievement Of a First Metabolic Complete Remission In a Lung Transtplanted Patient With Multiple Comorbidities and a CD30 Positive Anaplastic Large Cell Post-Transplant Lymphoproliferative Disorder (T-PTLD/ALCL) By Treatment With Brentuximab Vedotin Monotherapy

The KIT D816V Allele Burden in Systemic Mastocytosis Is Strongly Associated with Disease Subtype.

Pancytopenia a Presentation of disseminated Histoplasmosis

Crizotinib in ALK-Positive Diffuse Large B-Cell Lymphoma: A Case Report

Treatment of Burkitt's Like Lymphoma: A Single Institution Case Series

Critical Evaluation of Diverse Clinical, Laboratory, Radiological and Histological Parameters Indicating Gastrointestinal Involvement for Diagnosis of Indolent and Aggressive Systemic Mastocytosis

A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab In Relapsed CLL/SLL.

“Complete” Remission in Chronic Lymphocytic Leukemia (CLL) Is Strongly Affected by the Use of CT Scanning: Results from a Prospective Randomized Trial of Fludarabine Plus Cyclophosphamide (Flu/Cy) with or without Genasense (Oblimersen) in Patients with Relapsed or Refractory Disease.

Computed Tomography (CT) Predicts Response Duration in Patients with Chronic Lymphocytic Leukemia (CLL) in Complete Response (CR) by Conventional, NCI-Working Group, Criteria.

Prognostic Factors in Hodgkin’s Disease - Analysis of 211 Patients from a Single Institution.

Mitochondria Damage Leading to High Frequency of Lymphoma and Myeloproliferative Disorder in Transgenic Mice Overexpressing a Human 8-Oxoguanine DNA-Glycosylase Gene.

Follicular Dendritic Cell Sarcoma (FDCS): A Rare and Incurable Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only